XTX Topco Ltd Buys New Stake in The Cooper Companies, Inc. (NASDAQ:COO)

XTX Topco Ltd acquired a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 8,965 shares of the medical device company's stock, valued at approximately $824,000.

Other institutional investors have also added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of Cooper Companies in the fourth quarter worth about $217,906,000. FMR LLC increased its holdings in shares of Cooper Companies by 97.6% in the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after purchasing an additional 1,095,805 shares during the period. Raymond James Financial Inc. bought a new stake in Cooper Companies during the fourth quarter valued at $64,826,000. Victory Capital Management Inc. increased its stake in Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after acquiring an additional 573,908 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Cooper Companies stock traded up $0.39 during mid-day trading on Tuesday, reaching $79.09. 328,767 shares of the stock traded hands, compared to its average volume of 1,409,028. The business's 50-day moving average is $82.79 and its 200-day moving average is $93.29. The stock has a market capitalization of $15.82 billion, a PE ratio of 40.61, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The Cooper Companies, Inc. has a 12-month low of $69.81 and a 12-month high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of research analyst reports. Piper Sandler reaffirmed an "overweight" rating and set a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Robert W. Baird cut their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Citigroup lowered their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. lowered their target price on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.